NUS vs STEK
NU Skin Enterprises, Inc. and Stemtech Corp., side by side — 6 fiscal years reported in USD, drawn from SEC filings.
Most recent reported year
| Metric | NUS | STEK |
|---|---|---|
| Revenue | $1.5B | $2.9M |
| Net income | $160.2M | $-4.0M |
| Gross margin | 69.4% | 80.3% |
| Net margin | 10.8% | −140.8% |
| Return on equity | 22.0% | · |
| Diluted EPS | $3.18 | −$0.02 |
| Dividend / share | · | · |
| Payout ratio | 7.4% | · |
| Free cash flow | $46.0M | $-483,583 |
| Equity | $805.2M | $-7.0M |
| Net debt / equity | −0.02× | · |
| Current ratio | 2.08× | 0.04× |
| Revenue CAGR 5y | −10.5% | −8.1% |
| Profit CAGR 5y | −3.5% | · |
NUS bills 516.3× the revenue of STEK, and STEK closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
6 years side by side
| Fiscal year | NUS | STEK |
|---|---|---|
| FY2025 | $1.5B | $2.9M |
| FY2024 | $1.7B | $5.1M |
| FY2023 | $2.0B | $4.9M |
| FY2022 | $2.2B | $4.6M |
| FY2021 | $2.7B | $4.3M |
| FY2020 | $2.6B | $4.4M |
Bottom line
| Fiscal year | NUS | STEK |
|---|---|---|
| FY2025 | $160.2M | $-4.0M |
| FY2024 | $-146.6M | $-3.8M |
| FY2023 | $8.6M | $-5.4M |
| FY2022 | $104.8M | $-8.5M |
| FY2021 | $147.3M | $-7.1M |
| FY2020 | $191.4M | $-916,697 |
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +$1,482,282,620 | NUS |
| FY2024 | +$1,727,030,310 | NUS |
| FY2023 | +$1,964,209,469 | NUS |
| FY2022 | +$2,221,099,601 | NUS |
| FY2021 | +$2,691,347,755 | NUS |
| FY2020 | +$2,577,549,493 | NUS |
NUS has reported the higher revenue in every one of these 6 fiscal years. The gap has narrowed since the earliest year compared.
6 of 17 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +151.6 pp | NUS |
| FY2024 | +66.2 pp | NUS |
| FY2023 | +110.8 pp | NUS |
| FY2022 | +194.0 pp | NUS |
| FY2021 | +170.0 pp | NUS |
| FY2020 | +46.8 pp | NUS |
NUS has kept the higher net margin in every one of these 6 fiscal years.
6 of 17 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
STEK's net margin has been more volatile than NUS's over the 6 comparable fiscal years — 51.4 percentage points of standard deviation against 6.1.
6 of 17 comparable fiscal years — a year missing data on either side is not counted.
Year by year
NUS led in net margin in every one of the 6 comparable fiscal years — a structural lead, not a recent swing.
6 of 17 comparable fiscal years — a year missing data on either side is not counted.